Lawrence Blatt

Insider Reports History

Entity
Individual
Signature
/s/ Lesley Ann Calhoun, as attorney-in fact for Lawrence M. Blatt
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lawrence Blatt:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aligos Therapeutics, Inc. Chief Executive Officer, Director Common Stock 1.85M $1.4M $0.76 Oct 25, 2023 Direct
Aligos Therapeutics, Inc. Chief Executive Officer, Director Common Stock 18.5K $14K $0.76 Oct 25, 2023 Indirect
Aligos Therapeutics, Inc. Chief Executive Officer, Director Warrants (Right to Buy) 305K Oct 25, 2023 Direct
Aligos Therapeutics, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 33.9K Sep 4, 2024 Direct

Insider Reports Filed by Lawrence Blatt

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALGS Aligos Therapeutics, Inc. Sep 4, 2024 1 $0 4 Sep 6, 2024 Chief Executive Officer, Director
ALGS Aligos Therapeutics, Inc. Mar 1, 2024 1 $0 4 Mar 4, 2024 Chief Executive Officer, Director
ALGS Aligos Therapeutics, Inc. Feb 27, 2024 6 $0 4 Feb 28, 2024 Chief Executive Officer, Director
ALGS Aligos Therapeutics, Inc. Oct 25, 2023 2 $500K 4 Oct 27, 2023 Chief Executive Officer, Director
ALGS Aligos Therapeutics, Inc. Sep 8, 2023 1 $0 4 Sep 12, 2023 Chief Executive Officer
ALGS Aligos Therapeutics, Inc. Mar 15, 2023 1 $0 4 Mar 17, 2023 Chief Executive Officer
ALGS Aligos Therapeutics, Inc. Jul 7, 2022 1 $0 4 Jul 11, 2022 Chief Executive Officer
ALGS Aligos Therapeutics, Inc. Feb 4, 2022 2 $0 4 Feb 8, 2022 Chief Executive Officer